# FDA Inspection 796022 - Duke Clinical Research Institute - August 24, 2012

Source: https://www.keypedia.com/records/fda_inspections/duke-clinical-research-institute/8f1b68dc-6ed2-481a-acf9-b139a7cf05cb
Source feed: FDA_Inspections

> FDA Inspection 796022 for Duke Clinical Research Institute on August 24, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 796022
- Company Name: Duke Clinical Research Institute
- Inspection Date: 2012-08-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1081929 - 2019-01-17](https://www.keypedia.com/records/fda_inspections/duke-clinical-research-institute/29589990-3827-4c3e-bf49-905cc9e54f17)
- [FDA Inspection 953435 - 2015-11-04](https://www.keypedia.com/records/fda_inspections/duke-clinical-research-institute/87959370-6a66-494c-aa9f-39ef92b21d0f)
- [FDA Inspection 848158 - 2013-09-19](https://www.keypedia.com/records/fda_inspections/duke-clinical-research-institute/373752f0-79c4-44c1-b750-6d083ab15e63)

Company: https://www.keypedia.com/companies/duke-clinical-research-institute/b4576dbb-823b-42fb-83a4-9bc304e2adbb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c